share_log

Adastra Holdings Announces Record Single Purchase Order For Over $1M

Adastra Holdings Announces Record Single Purchase Order For Over $1M

Adastra Holdings宣佈創紀錄的單一採購訂單,金額超過100萬美元
Accesswire ·  03/02 06:00

LANGLEY, BC / ACCESSWIRE / March 1, 2024 / Adastra Holdings Ltd. (CSE:XTRX)(FRA:D2E) ("Adastra" or the "Company"), a leading cannabis processor and producer of two top Canadian concentrates brands, with a focus on product innovation and commercialization for adult-use and medical markets, is pleased to announce that it has received a Purchase Order ("PO") for CAD $1,047,439 from the Alberta Gaming, Liquor & Cannabis ("AGLC").

不列顛哥倫比亞省蘭利 /ACCESSWIRE/2024 年 3 月 1 日/Adastra Holdings Ltd. (CSE: XTRX)(FRA: D2E)(“Adastra” 或 “公司”)是一家領先的大麻加工商和加拿大兩個頂級濃縮物品牌的生產商,專注於成人用和醫療市場的產品創新和商業化,很高興地宣佈,它已收到一份採購訂單(“PO”)來自艾伯塔省博彩、烈酒和大麻協會(“AGLC”)的1,047,439加元。

Adastra's PO from the AGLC is the largest single PO in Adastra's history. The PO was secured by the Company in early February and included a wide range of Adastra's product mix, including offerings from its in-house brand, Endgame Extracts ("Endgame"). This PO signals the strong position the Endgame brand has in Alberta which, according to Headset, holds four of the top ten selling concentrate brands[1] and two of the top ten selling vapor pen brands[2].

來自AGLC的Adastra的PO是Adastra歷史上最大的單一訂貨單。該公司於2月初獲得了該訂單,其中包括Adastra的各種產品組合,包括其內部品牌Endgame Extracts(“Endgame”)的產品。該採購訂單表明了Endgame品牌在艾伯塔省的強勢地位,根據Headset的數據,該品牌在十大暢銷濃縮液品牌中佔有四個 [1],在十大最暢銷的蒸汽筆品牌中佔有兩個 [2]。

CEO Update

首席執行官最新消息

On February 29th, 2024, Michael Forbes resigned as CEO, Director and Corporate Secretary, effective March 29, 2024. Mr. Forbes will be focusing on his other ventures in the cannabis and health space, including Ageless Living, longevity-based interdisciplinary clinics.

2 月 29 日第四2024 年,邁克爾·福布斯辭去首席執行官、董事兼公司秘書的職務,自 2024 年 3 月 29 日起生效。福布斯先生將專注於他在大麻和健康領域的其他業務,包括以長壽爲基礎的跨學科診所Ageless Living。

The Company is currently in the process of selecting and approving a new CEO and hopes to make an announcement later this month. Mr. Forbes has advised the Board of Directors of his willingness to support Adastra during this period of transition to ensure an orderly leadership transition to his successor.

該公司目前正在甄選和批准新的首席執行官,並希望在本月晚些時候發佈公告。福布斯先生已告知董事會,他願意在這段過渡期間支持Adastra,以確保領導層有序過渡到繼任者。

"When Michael joined Adastra in April 2021, the Company's quarterly revenues stood at $1.2 million. Fast forward nearly three years, and we're thrilled to receive our largest single purchase order to date, exceeding $1 million. This order is nearly the same amount as the quarterly revenue figure from when Michael first joined. This remarkable milestone underscores Michael's profound impact as CEO, driving revenue growth and scaling operations at Adastra," said Lachlan McLeod, Chief Financial Officer. "We thank Michael for his leadership and guidance during his tenure as CEO. As Michael plans to focus his time on his other ventures, we extend our best wishes for his continued success."

“當邁克爾於2021年4月加入阿達斯特拉時,該公司的季度收入爲120萬美元。快進了將近三年,我們很高興收到迄今爲止最大的單筆採購訂單,金額超過100萬美元。該訂單的金額與邁克爾首次加入時的季度收入數字幾乎相同。這一非凡的里程碑凸顯了邁克爾作爲首席執行官的深遠影響,推動了Adastra的收入增長並擴大了運營規模。” 首席財務官拉克蘭·麥克勞德說。“我們感謝邁克爾在擔任首席執行官期間的領導和指導。由於邁克爾計劃將時間集中在其他事業上,我們祝願他繼續取得成功。”

"It has been an honour and privilege to have served as CEO of Adastra during this significant restructuring phase. I am proud of where the Company is today. Receiving our largest single purchase order of over $1 million is truly a testament to the hard work and dedication of our team. This milestone reflects not only our commitment to excellence but also the trust and confidence our customers have in our premium products," said Michael Forbes, CEO of Adastra.

“在這個重大重組階段擔任Adastra的首席執行官是一種榮幸和榮幸。我爲公司今天的狀況感到自豪。收到我們超過100萬美元的最大單一採購訂單確實證明了我們團隊的辛勤工作和奉獻精神。這一里程碑不僅反映了我們對卓越的承諾,也反映了客戶對我們優質產品的信任和信心。” Adastra首席執行官邁克爾·福布斯說。

"As we move forward, I am confident that Adastra will continue to thrive and achieve even greater success. I am committed to ensuring a smooth transition to the next management team. I want to express my deepest gratitude to everyone who has been part of this journey, from our employees to our shareholders and partners. Together, we have overcome challenges and seized opportunities, and I am excited to see what the future holds for the Company. Adastra means to the stars and I still believe that to this day."

“在我們向前邁進的過程中,我相信Adastra將繼續蓬勃發展並取得更大的成功。我致力於確保順利過渡到下一個管理團隊。我要向所有參與這段旅程的人表示最深切的感謝,從我們的員工到我們的股東和合作夥伴。我們共同克服了挑戰,抓住了機遇,我很高興看到公司的未來會怎樣。阿達斯特拉對星星來說意義重大,直到今天我仍然相信這一點。”

About Adastra Holdings Ltd.

關於阿達斯特拉控股有限公司

Adastra has become one of Canada's leaders in the supply and manufacturing of ethnobotanical and cannabis products for lawful adult-use. It serves medical markets and engages in forward-looking therapeutic applications. With cannabis concentrate products sold through retailers at more than 2,000 locations across Canada, Adastra's Phyto Extractions and Endgame Extracts brands are now well established with a growing distribution presence. As a Health Canada licensed facility, it specializes in extraction, distillation and manufacturing of a range of cannabis-derived products. Adastra partners with healthcare professionals and practitioners within the regulated environment to create products suitable for the medical cannabis market, with the ultimate aim of addressing the needs of patients. For more information, visit: .

Adastra已成爲加拿大供應和製造供成人合法使用的民族植物學和大麻產品的領導者之一。它服務於醫療市場並從事前瞻性治療應用。隨着大麻濃縮物產品通過零售商在加拿大2,000多個地點銷售,Adastra的植物提取物和殘局提取物品牌現已樹立了良好的聲譽,分銷業務不斷增長。作爲加拿大衛生部許可的機構,它專門從事一系列大麻衍生產品的提取、蒸餾和製造。Adastra與監管環境中的醫療保健專業人員和從業人員合作,開發適合醫用大麻市場的產品,最終目標是滿足患者的需求。欲了解更多信息,請訪問:.

Contacts

聯繫人

Michael Forbes, CEO, Corporate Secretary & Director
(778) 715-5011
michael@adastraholdings.ca

邁克爾·福布斯,首席執行官、公司秘書兼董事
(778) 715-5011
michael@adastraholdings.ca

Forward-Looking Information

前瞻性信息

This news release contains forward‐looking information within the meaning of Canadian securities legislation concerning the business of the Company. Forward‐looking information is based on certain key expectations and assumptions made by the management of the Company. Although the Company believes that the expectations and assumptions on which such forward looking information is based are reasonable, undue reliance should not be placed on the forward‐looking information because the Company can give no assurance that they will prove to be correct. Forward looking information is often identified by the words "may", "would", "could", "should", "will", "intend", "plan", "anticipate", "believe", "estimate", "expect" or similar expressions and in this news release includes statements regarding, but not limited to the expectation for future growth, the anticipation of creating long‐term value for customers, partners and shareholders, the timeline for identifying a new CEO, the expectation for even greater success for the Company, and expectations for other economic, business, and/or competitive factors. There are numerous risks and uncertainties that could cause actual results and the Company's plans and objectives to differ materially from those expressed in the forward‐looking information. Important factors that could cause actual results to differ materially from those expressed in the forward‐looking information include: the availability of a qualified workforce; changes in regulations or licensing affecting the Company's business; reduced demand for cannabis and cannabis related products; reductions in the Company's retail space and store locations; changes in consumer brand preferences; and other factors beyond the control of the Company, including the risk factors set out in the Company's annual report on Form 20-F dated May 16, 2023, filed with Canadian securities regulators and available on the Company's profile on SEDAR+ at . These and all subsequent written and oral forward‐looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Company does not intend to update these forward‐looking statements.

本新聞稿包含與公司業務有關的加拿大證券立法所指的前瞻性信息。前瞻性信息基於公司管理層做出的某些關鍵預期和假設。儘管公司認爲此類前瞻性信息所依據的預期和假設是合理的,但不應過分依賴前瞻性信息,因爲公司無法保證這些信息將被證明是正確的。前瞻性信息通常用 “可能”、“將”、“可以”、“應該”、“打算”、“計劃”、“預期”、“相信”、“估計”、“期望” 或類似表述來識別。在本新聞稿中,包括但不限於對未來增長的預期、爲客戶、合作伙伴和股東創造長期價值的預期、確定前瞻性信息的時間表的聲明新任首席執行官,對公司取得更大成功的期望,以及對其他經濟、業務和/或競爭因素的期望。存在許多風險和不確定性,可能導致實際業績和公司的計劃和目標與前瞻性信息中表達的計劃和目標存在重大差異。可能導致實際業績與前瞻性信息中表達的結果存在重大差異的重要因素包括:合格員工隊伍的可用性;影響公司業務的法規或許可的變化;對大麻和大麻相關產品的需求減少;公司零售空間和門店位置的減少;消費者品牌偏好的變化;以及公司無法控制的其他因素,包括公司5月20-F表年度報告中列出的風險因素 2023 年 16 日,已提交可在加拿大證券監管機構處查閱,可在SEDAR+上查看該公司的簡介,網址爲。這些信息以及隨後的所有書面和口頭前瞻性信息均基於管理層對這些信息發佈日期的估計和意見,本通知對這些信息進行了明確的全面限定。除非法律要求,否則公司不打算更新這些前瞻性陳述。

[1]

[1]

[2]

[2]

SOURCE: Adastra Holdings Ltd.

來源:Adastra Holdings Ltd.


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論